Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Treasury Shares (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Treasury Shares for 16 consecutive years, with $1.2 million as the latest value for Q1 2026.

  • For Q1 2026, Treasury Shares fell 34.97% year-over-year to $1.2 million; the TTM value through Mar 2026 reached $1.2 million, down 34.97%, while the annual FY2025 figure was $1.7 million, 49.03% up from the prior year.
  • Treasury Shares hit $1.2 million in Q1 2026 for Acadia Healthcare Company, up from $249752.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.8 million in Q1 2025 and bottomed at $249752.0 in Q4 2025.
  • Average Treasury Shares over 5 years is $981432.5, with a median of $1.1 million recorded in 2022.
  • On a YoY basis, Treasury Shares climbed as much as 522.23% in 2025 and fell as far as 78.2% in 2025.
  • Acadia Healthcare Company's Treasury Shares stood at $1.3 million in 2022, then fell by 19.1% to $1.0 million in 2023, then grew by 11.15% to $1.1 million in 2024, then tumbled by 78.2% to $249752.0 in 2025, then surged by 376.26% to $1.2 million in 2026.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.2 million, $249752.0, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.